Skip to main content

Table 1 Demographic and clinical characteristics of VL patients

From: High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis

Variables (pre-treatment)

VL patients (n = 45)

Age (mean ± SD)

15 ± 15 years

Males n (%)

25 (55.5%)

Spleen size (mean ± SD)

9.1 ± 4.08

White blood cell count

3035 ± 1351

Neutrophils

1041 ± 745.2

Platelets

181, 21 ± 63,844

Hb

8.475 ± 1.264

Confirmatory of VL

 

r  K39 (n = 45)

100%

L  eishmania culture (n = 17)

100%

Parasite load (n = 15)

100%

AST (mean ± SD)

119.6 ± 188.4U/ml

ALT (mean ± SD)

79.20 ± 103.4U/ml

  1. Hb hemoglobine.
  2. VL Visceral leishmaniasis.
  3. rK39 serological test specific for Kalazar.
  4. AST Aspartate aminotransferase.
  5. ALT Alanine aminotransferase.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us